ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations

Vejle Hospital · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
cholangiocarcinomamonoclonalantibody
cholangiocarcinoma, inoperable, kras mutation, biological treatment, combination chemotherapy, monoclonal antibody, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 833525
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.